The cost-effectiveness of adjunctive corticosteroids for patients with septic shock.
CONCLUSIONS: Adjunctive hydrocortisone did not significantly affect longer term mortality, health-related quality of life, health care resource use or costs, and is unlikely to be cost-effective.
PMID: 32900325 [PubMed - in process]
Source: Critical Care and Resuscitation - Category: Intensive Care Tags: Crit Care Resusc Source Type: research
More News: Clinical Trials | Corticosteroid Therapy | Databases & Libraries | Health Management | Hydrocortisone | Intensive Care | Septic Shock | Wales Health